{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:48:26Z","timestamp":1766566106642,"version":"3.48.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,24]]},"DOI":"10.7759\/cureus.99986","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:30:54Z","timestamp":1766565054000},"source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Bacillus Calmette-Gu\u00e9rin (BCG) Revaccination on COVID-19 Infection Among Healthcare Workers: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Hosam Hadi","family":"Hassan Awaji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayan N","family":"Sahli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawzyh B","family":"Albalwi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasayef S","family":"Albalawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teef A","family":"Muhawish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana M","family":"Albalawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal K","family":"Alsubiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawaher S","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabiah","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawziyah S","family":"Qarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouf","family":"Abu Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fida N","family":"Albalawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-induced cross-protection and development of trained immunity: implication for vaccine design","volume":"10","author":"Covi\u00e1n C","year":"2019","unstructured":"Covi\u00e1n C, Fern\u00e1ndez-Fierro A, Retamal-D\u00edaz A, et al.. BCG-induced cross-protection and development of trained immunity: implication for vaccine design. Front Immunol. 2019, 10:2806. 10.3389\/fimmu.2019.02806","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12081295","article-title":"Global challenges to public health care systems during the COVID-19 pandemic: a review of pandemic measures and problems","volume":"12","author":"Filip R","year":"2022","unstructured":"Filip R, Gheorghita Puscaselu R, Anchidin-Norocel L, Dimian M, Savage WK. Global challenges to public health care systems during the COVID-19 pandemic: a review of pandemic measures and problems. J Pers Med. 2022, 12:8-9. 10.3390\/jpm12081295","journal-title":"J Pers Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2021.100249","article-title":"Variances in BCG protection against COVID-19 mortality: a global assessment","volume":"24","author":"Sarfraz Z","year":"2021","unstructured":"Sarfraz Z, Sarfraz A, Pandav K, et al.. Variances in BCG protection against COVID-19 mortality: a global assessment. J Clin Tuberc Other Mycobact Dis. 2021, 24:100249. 10.1016\/j.jctube.2021.100249","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109208","article-title":"The impact of BCG dose and revaccination on trained immunity","volume":"246","author":"Debisarun PA","year":"2023","unstructured":"Debisarun PA, Kilic G, de Bree LC, et al.. The impact of BCG dose and revaccination on trained immunity. Clin Immunol. 2023, 246:109208. 10.1016\/j.clim.2022.109208","journal-title":"Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000002370","article-title":"Efficacy and outcomes of BCG re-vaccination in COVID-19: a systematic review, meta-analysis, and meta-regression of randomized controlled trials","volume":"86","author":"Jain H","year":"2024","unstructured":"Jain H, Odat RM, Hussein AM, et al.. Efficacy and outcomes of BCG re-vaccination in COVID-19: a systematic review, meta-analysis, and meta-regression of randomized controlled trials. Ann Med Surg (Lond). 2024, 86:5439-46. 10.1097\/MS9.0000000000002370","journal-title":"Ann Med Surg (Lond)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1118378","article-title":"Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19","volume":"14","author":"Du J","year":"2023","unstructured":"Du J, Su Y, Wang R, Dong E, Cao Y, Zhao W, Gong W. Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19. Front Immunol. 2023, 14:1118378. 10.3389\/fimmu.2023.1118378","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati A","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al.. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009, 6:e1000100. 10.1371\/journal.pmed.1000100","journal-title":"PLoS Med"},{"key":"ref8","unstructured":"The social care guidance manual Process and methods [PMG10]. Appendix B. Methodology checklist. (2021). Accessed: December 23, 2025: https:\/\/www.nice.org.uk\/process\/pmg10\/chapter\/appendix-b-methodology-checklist-systematic-reviews-and-meta-analyses."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.841868","article-title":"Efficacy and safety of BCG revaccination with M. bovis BCG Moscow to prevent COVID-19 infection in health care workers: a randomized phase II clinical trial","volume":"13","author":"Dos Anjos LR","year":"2022","unstructured":"Dos Anjos LR, da Costa AC, Cardoso AD, et al.. Efficacy and safety of BCG revaccination with M. bovis BCG Moscow to prevent COVID-19 infection in health care workers: a randomized phase II clinical trial. Front Immunol. 2022, 13:841868. 10.3389\/fimmu.2022.841868","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00356-23","article-title":"BCG vaccination of health care workers does not reduce SARS-CoV-2 infections nor infection severity or duration: a randomized placebo-controlled trial","volume":"14","author":"Claus J","year":"2023","unstructured":"Claus J, Ten Doesschate T, Gumbs C, et al.. BCG vaccination of health care workers does not reduce SARS-CoV-2 infections nor infection severity or duration: a randomized placebo-controlled trial. mBio. 2023, 14:e0035623. 10.1128\/mbio.00356-23","journal-title":"mBio"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10020314","article-title":"A multi-center, randomised, double-blind, placebo-controlled phase III clinical trial evaluating the impact of BCG re-vaccination on the incidence and severity of SARS-CoV-2 infections among symptomatic healthcare professionals during the COVID-19 pandemic in Poland-first results","volume":"10","author":"Czajka H","year":"2022","unstructured":"Czajka H, Zapolnik P, Krzych \u0141, et al.. A multi-center, randomised, double-blind, placebo-controlled phase III clinical trial evaluating the impact of BCG re-vaccination on the incidence and severity of SARS-CoV-2 infections among symptomatic healthcare professionals during the COVID-19 pandemic in Poland-first results. Vaccines (Basel). 2022, 10:6-8. 10.3390\/vaccines10020314","journal-title":"Vaccines (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.04.009","article-title":"Bacillus Calmette-Gu\u00e9rin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial","volume":"28","author":"Ten Doesschate T","year":"2022","unstructured":"Ten Doesschate T, van der Vaart TW, Debisarun PA, et al.. Bacillus Calmette-Gu\u00e9rin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial. Clin Microbiol Infect. 2022, 28:1278-85. 10.1016\/j.cmi.2022.04.009","journal-title":"Clin Microbiol Infect"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf007","article-title":"BCG-induced DNA methylation changes improve coronavirus disease 2019 vaccine immunity without decreasing the risk for severe acute respiratory syndrome coronavirus 2 infection","volume":"12","author":"Carrero Longlax S","year":"2025","unstructured":"Carrero Longlax S, Koster KJ, Kamat AM, et al.. BCG-induced DNA methylation changes improve coronavirus disease 2019 vaccine immunity without decreasing the risk for severe acute respiratory syndrome coronavirus 2 infection. Open Forum Infect Dis. 2025, 12:ofaf007. 10.1093\/ofid\/ofaf007","journal-title":"Open Forum Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad422","article-title":"Using BCG vaccine to enhance nonspecific protection of health care workers during the COVID-19 pandemic: a randomized controlled trial","volume":"229","author":"Madsen AM","year":"2024","unstructured":"Madsen AM, Schaltz-Buchholzer F, Nielsen S, et al.. Using BCG vaccine to enhance nonspecific protection of health care workers during the COVID-19 pandemic: a randomized controlled trial. J Infect Dis. 2024, 229:384-93. 10.1093\/infdis\/jiad422","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106245","article-title":"BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial","volume":"89","author":"Messina NL","year":"2024","unstructured":"Messina NL, Pittet LF, McDonald E, et al.. BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial. J Infect. 2024, 89:106245. 10.1016\/j.jinf.2024.106245","journal-title":"J Infect"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00818-6","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial","volume":"24","author":"Dos Santos PC","year":"2024","unstructured":"Dos Santos PC, Messina NL, de Oliveira RD, et al.. Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial. Lancet Infect Dis. 2024, 24:594-601. 10.1016\/S1473-3099(23)00818-6","journal-title":"Lancet Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101414","article-title":"Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: a double-blind, randomised, controlled, phase 3 trial","volume":"48","author":"Upton CM","year":"2022","unstructured":"Upton CM, van Wijk RC, Mockeliunas L, et al.. Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: a double-blind, randomised, controlled, phase 3 trial. EClinicalMedicine. 2022, 48:101414. 10.1016\/j.eclinm.2022.101414","journal-title":"EClinicalMedicine"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway NR","year":"2022","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev. 2022, 18:e1230. 10.1002\/cl2.1230","journal-title":"Campbell Syst Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00028-20","article-title":"Coronavirus disease 2019-COVID-19","volume":"33","author":"Dhama K","year":"2020","unstructured":"Dhama K, Khan S, Tiwari R, et al.. Coronavirus disease 2019-COVID-19. Clin Microbiol Rev. 2020, 33:5-7. 10.1128\/CMR.00028-20","journal-title":"Clin Microbiol Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2020.12.018","article-title":"Is the BCG vaccine a useful tool against COVID-19?","volume":"39","author":"Zhelezova G","year":"2021","unstructured":"Zhelezova G, Mateeva V, Mateev G. Is the BCG vaccine a useful tool against COVID-19?. Clin Dermatol. 2021, 39:98-103. 10.1016\/j.clindermatol.2020.12.018","journal-title":"Clin Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108870","article-title":"BCG vaccination: a potential tool against COVID-19 and COVID-19-like Black Swan incidents","volume":"108","author":"Gong W","year":"2022","unstructured":"Gong W, Mao Y, Li Y, Qi Y. BCG vaccination: a potential tool against COVID-19 and COVID-19-like Black Swan incidents. Int Immunopharmacol. 2022, 108:108870. 10.1016\/j.intimp.2022.108870","journal-title":"Int Immunopharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12031154","article-title":"Efficacy of BCG vaccination against COVID-19: systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Wen J","year":"2023","unstructured":"Wen J, Liu Q, Tang D, He JQ. Efficacy of BCG vaccination against COVID-19: systematic review and meta-analysis of randomized controlled trials. J Clin Med. 2023, 12:22-3. 10.3390\/jcm12031154","journal-title":"J Clin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0321511","article-title":"Efficacy of BCG vaccination against COVID-19 in health care workers and non-health care workers: a meta-analysis of randomized controlled trials","volume":"20","author":"Xia Z","year":"2025","unstructured":"Xia Z, Meng J, Wang X, et al.. Efficacy of BCG vaccination against COVID-19 in health care workers and non-health care workers: a meta-analysis of randomized controlled trials. PLoS One. 2025, 20:e0321511. 10.1371\/journal.pone.0321511","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/440265-the-impact-of-bacillus-calmette-gurin-bcg-revaccination-on-covid-19-infection-among-healthcare-workers-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:30:55Z","timestamp":1766565055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/440265-the-impact-of-bacillus-calmette-gurin-bcg-revaccination-on-covid-19-infection-among-healthcare-workers-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.99986","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,24]]}}}